Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
AB van der Waart, NMP van de Weem… - Blood, The Journal …, 2014 - ashpublications.org
Effective T-cell therapy against cancer is dependent on the formation of long-lived, stem cell–
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
[HTML][HTML] Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
AB van der Waart, MPN van de Weem, F Maas… - Blood, 2014 - Elsevier
Effective T-cell therapy against cancer is dependent on the formation of long-lived, stem cell–
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
AB van der Waart, NMP van de Weem, F Maas… - …, 2014 - pubmed.ncbi.nlm.nih.gov
Effective T-cell therapy against cancer is dependent on the formation of long-lived, stem cell-
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
[PDF][PDF] Inhibition of Akt-signaling promotes the generation of superior tumour-reactive T cells for adoptive immunotherapy.
AB van der Waart, NMP van de Weem… - Immune therapy in …, 2015 - repository.ubn.ru.nl
Effective T cell therapy against cancer is dependent on the formation of long-lived, stem cell-
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
[PDF][PDF] Inhibition of Akt-signaling promotes the generation of superior tumour-reactive T cells for adoptive immunotherapy.
AB van der Waart, NMP van de Weem, F Maas… - Immune therapy in …, 2015 - core.ac.uk
Effective T cell therapy against cancer is dependent on the formation of long-lived, stem cell-
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.
AB van der Waart, NM van de Weem, F Maas… - Blood, 2014 - europepmc.org
Effective T-cell therapy against cancer is dependent on the formation of long-lived, stem cell–
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
[引用][C] Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
AB van der Waart, NMP van de Weem… - …, 2014 - scholarlypublications …
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive
immunotherapy | Scholarly Publications Skip to main content Universiteit Leiden Leiden …
immunotherapy | Scholarly Publications Skip to main content Universiteit Leiden Leiden …
[HTML][HTML] Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
AB van der Waart, NMP van de Weem, F Maas… - Blood, 2014 - ncbi.nlm.nih.gov
Effective T-cell therapy against cancer is dependent on the formation of long-lived, stem cell–
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.
AB van der Waart, NM van de Weem, F Maas… - Blood, 2014 - europepmc.org
Effective T-cell therapy against cancer is dependent on the formation of long-lived, stem cell–
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
[HTML][HTML] Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
AB van der Waart, MPN van de Weem, F Maas… - Blood, 2014 - Elsevier
Effective T-cell therapy against cancer is dependent on the formation of long-lived, stem cell–
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …
like T cells with the ability to self-renew and differentiate into potent effector cells. Here, we …